Roxarsone Delivery Nanocomposite Based on Nitrite‐Functionalized Mesoporous Polydopamine for Multidrug‐Resistant Bacterial Infections via Enhanced Chemo‐Photothermal Therapy

Author:

Kang Zhecheng1ORCID,Zhou Qian1,Wang Kun1,Wang An1,Chen Tianyi1,Wei Hongbo2,Wang Tengjiao13ORCID

Affiliation:

1. Frontiers Science Center for Flexible Electronics (FSCFE) Xi'an Institute of Flexible Electronics (IFE) & Xi'an Institute of Biomedical Materials and Engineering (IBME) Northwestern Polytechnical University (NPU) Xi'an Shaanxi 710072 P. R. China

2. State Key Laboratory of Military Stomatology & National Clinical Research Center for Oral Diseases & Shaanxi Engineering Research Center for Dental Materials and Advanced Manufacture Department of Oral Implants School of Stomatology The Fourth Military Medical University Xi'an Shaanxi P. R. China

3. Research & Development Institute of Northwestern Polytechnical University in Shenzhen Shenzhen Guangdong 518057 P. R. China

Abstract

AbstractCurrent treatments for infections caused by multidrug‐resistant bacteria still remain challenging and therapeutic materials with high efficacy are of demand. Herein, a bactericidal nanocomposite was constructed by loading Roxarsone (ROX) onto nitrosylated mesoporous polydopamine (named mPDA@NO‐ROX). The designed nanocomposite exhibited considerable photothermal effect and controlled NO and ROX co‐delivery under the irradiation of near‐infrared laser (NIR) to achieve enhanced chemo‐photothermal antibacterial therapy. The in vitro antibacterial evaluation of the mPDA@NO‐ROX demonstrated the effective elimination of the Gram‐negative tetracycline‐resistant Escherichia coil and Gram‐positive methicillin‐resistant Staphylococcus aureus under mild NIR irradiation compared to merely ROX loaded unmodified mPDA, indicating the NO enhanced chemo‐photothermal therapy. In addition, the cytotoxicity experiments indicated that mPDA@NO‐ROX exhibited only 5 % of hemolysis rate and high cell viability at 1 mg mL−1 against mammalian fibroblasts, suggesting the excellent biocompatibility. In conclusion, the mPDA@NO‐ROX could be a promising candidate for anti‐infection therapy of multidrug‐resistant bacteria.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3